| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0076 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0069 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0078 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |